Freyssin, A., Carles, A., Moha, B., Rubinstenn, G., & Maurice, T. (2024). Long-Term Treatment with Fluoroethylnormemantine (FENM) Alleviated Memory Deficits, Amyloid Pathology, and Microglial Reaction in APP/PS1 Mice. ACS Pharmacology & Translational Science, 7(12), 4069-4082. https://doi.org/10.1021/acsptsci.4c00522
Chicago-referens (17:e uppl.)Freyssin, Aline, Allison Carles, Barbara Moha, Gilles Rubinstenn, och Tangui Maurice. "Long-Term Treatment with Fluoroethylnormemantine (FENM) Alleviated Memory Deficits, Amyloid Pathology, and Microglial Reaction in APP/PS1 Mice." ACS Pharmacology & Translational Science 7, no. 12 (2024): 4069-4082. https://doi.org/10.1021/acsptsci.4c00522.
MLA-referens (9:e uppl.)Freyssin, Aline, et al. "Long-Term Treatment with Fluoroethylnormemantine (FENM) Alleviated Memory Deficits, Amyloid Pathology, and Microglial Reaction in APP/PS1 Mice." ACS Pharmacology & Translational Science, vol. 7, no. 12, 2024, pp. 4069-4082, https://doi.org/10.1021/acsptsci.4c00522.
